Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Merck & Co. Inc. buy TD Cowen

Start price
€105.40
04.01.24 / 50%
Target price
€123.30
04.01.25
Performance (%)
-8.73%
End price
€96.20
05.01.25
Summary
This prediction ended on 05.01.25 with a price of €96.20. With a performance of -8.73%, the BUY prediction by TD_Cowen finished with a loss. A total of €2.89 was paid as dividends for this prediction. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Merck & Co. Inc. 1.198% 1.198% -11.518%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by TD_Cowen for this prediction

In the thread Merck & Co. Inc. diskutieren
Prediction Buy
Perf. (%) -8.73%
Target price 123.296
Change
Ends at 04.01.25

Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at TD Cowen from a "market perform" rating to an "outperform" rating. They now have a $135.00 price target on the stock, up previously from $125.00.
Ratings data for MRK provided by MarketBeat

In the thread Trading Merck & Co. Inc.
Prediction Buy
Perf. (%) -8.73%
Target price 123.296
Change
Ends at 04.01.25

Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten